Star Equity (STRR) Competitors $2.59 -0.01 (-0.38%) As of 03/27/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STRR vs. DRIO, SURG, PTHL, RVP, VVOS, XAIR, NXGL, IRIX, QTI, and LFWDShould you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include DarioHealth (DRIO), SurgePays (SURG), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Retractable Technologies (RVP), Vivos Therapeutics (VVOS), Beyond Air (XAIR), NEXGEL (NXGL), IRIDEX (IRIX), QT Imaging (QTI), and ReWalk Robotics (LFWD). These companies are all part of the "medical equipment" industry. Star Equity vs. DarioHealth SurgePays Pheton Holdings Ltd Class A Ordinary Shares Retractable Technologies Vivos Therapeutics Beyond Air NEXGEL IRIDEX QT Imaging ReWalk Robotics Star Equity (NASDAQ:STRR) and DarioHealth (NASDAQ:DRIO) are both small-cap multi-sector conglomerates companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings, risk and community ranking. Is STRR or DRIO more profitable? Star Equity has a net margin of -12.41% compared to DarioHealth's net margin of -205.62%. Star Equity's return on equity of -8.72% beat DarioHealth's return on equity.Company Net Margins Return on Equity Return on Assets Star Equity-12.41% -8.72% -4.62% DarioHealth -205.62%-72.16%-40.74% Do analysts prefer STRR or DRIO? DarioHealth has a consensus target price of $1.50, indicating a potential upside of 128.73%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts plainly believe DarioHealth is more favorable than Star Equity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Star Equity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DarioHealth 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders and institutionals have more ownership in STRR or DRIO? 3.8% of Star Equity shares are held by institutional investors. Comparatively, 33.4% of DarioHealth shares are held by institutional investors. 33.5% of Star Equity shares are held by insiders. Comparatively, 10.9% of DarioHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, STRR or DRIO? Star Equity has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Does the media favor STRR or DRIO? In the previous week, Star Equity had 6 more articles in the media than DarioHealth. MarketBeat recorded 9 mentions for Star Equity and 3 mentions for DarioHealth. DarioHealth's average media sentiment score of 0.97 beat Star Equity's score of 0.37 indicating that DarioHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Star Equity 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral DarioHealth 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor STRR or DRIO? DarioHealth received 236 more outperform votes than Star Equity when rated by MarketBeat users. However, 100.00% of users gave Star Equity an outperform vote while only 66.95% of users gave DarioHealth an outperform vote. CompanyUnderperformOutperformStar EquityOutperform Votes3100.00% Underperform VotesNo VotesDarioHealthOutperform Votes23966.95% Underperform Votes11833.05% Which has higher earnings and valuation, STRR or DRIO? Star Equity has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStar Equity$53.36M0.16$25.13M-$3.91-0.67DarioHealth$27.04M1.01-$59.43M-$0.62-1.06 SummaryDarioHealth beats Star Equity on 10 of the 18 factors compared between the two stocks. Remove Ads Get Star Equity News Delivered to You Automatically Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STRR vs. The Competition Export to ExcelMetricStar EquityElectromedical equipment IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$8.47M$3.25B$13.23B$8.06BDividend YieldN/A1.63%3.33%4.02%P/E Ratio-1.0214.899.6219.03Price / Sales0.1642.733.8893.17Price / Cash6.1144.0913.3534.64Price / Book0.183.452.014.33Net Income$25.13M$89.74M$959.43M$247.06M7 Day Performance19.05%-1.11%-0.74%-0.52%1 Month Performance17.98%-8.54%-1.76%-3.73%1 Year Performance-41.21%-15.37%-7.10%1.74% Star Equity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STRRStar Equity1.2674 of 5 stars$2.63+1.2%N/A-41.2%$8.47M$53.36M-1.02460Analyst RevisionDRIODarioHealth2.7782 of 5 stars$0.69+3.0%$1.50+118.7%-56.9%$27.68M$27.04M-0.73200SURGSurgePays3.1239 of 5 stars$1.21+2.5%$8.50+602.5%-41.6%$24.40M$83.60M-1.0740Earnings ReportOptions VolumeAnalyst RevisionNews CoverageGap DownPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$3.67-12.2%N/AN/A$24.16M$572,291.000.0011RVPRetractable TechnologiesN/A$0.71-4.8%N/A-37.3%$21.40M$38.27M-1.32240Analyst ForecastNews CoveragePositive NewsVVOSVivos Therapeutics2.5713 of 5 stars$3.58+8.5%$6.30+76.0%-30.0%$21.09M$14.58M-0.63160Short Interest ↓XAIRBeyond Air4.5857 of 5 stars$0.30+12.3%$3.67+1,115.7%-83.8%$20.75M$3.02M-0.2870High Trading VolumeNXGLNEXGEL0.8938 of 5 stars$2.88+3.2%N/A+14.2%$19.56M$6.73M-4.9710Earnings ReportIRIXIRIDEX1.2617 of 5 stars$1.07-5.3%$2.00+86.9%-70.1%$17.80M$48.43M-1.60120Earnings ReportAnalyst ForecastQTIQT ImagingN/A$0.63+8.2%N/A-44.1%$17.03M$4.00M0.00N/APositive NewsGap DownLFWDReWalk Robotics2.4646 of 5 stars$1.59+5.3%$9.00+466.0%-63.7%$16.90M$25.66M-0.6460Short Interest ↑ Remove Ads Related Companies and Tools Related Companies DarioHealth Competitors SurgePays Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors Retractable Technologies Competitors Vivos Therapeutics Competitors Beyond Air Competitors NEXGEL Competitors IRIDEX Competitors QT Imaging Competitors ReWalk Robotics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STRR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Star Equity Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Star Equity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.